To fully unravel the roles of C9orf9 splicing mutations in CRC, based on our research, further experiments are required to elucidate the underlying mechanism, including CRISPR/Cas9-based point mutation in CRC cells. Here, SPACA9 is linked to colorectal carcinoma.